Opinion|Videos|July 23, 2024

NCCN Recommendations by PD-L1 Expression Level

A panel of experts discuss how the NCCN guideline recommendations differ for patients with and without PD-L1 expression.

Video content above is prompted by the following:

  • How do the NCCN guideline recommendations differ for patients without PD-L1 expression (<1%) compared with those with low (1%-49%) or high (≥50%) expression?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.


Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text